Isoprenaline (Isoproterenol): Clinical Overview
Isoprenaline is a second-line agent with limited indications—primarily reserved for bradycardia refractory to atropine and pacing, bronchospasm during anesthesia, and specific electrophysiology laboratory applications, but should be avoided when coronary ischemia is a concern due to its adverse effect of increasing myocardial oxygen demand while decreasing coronary perfusion.
Primary Indications
1. Hemodynamically Unstable Bradycardia
Isoprenaline serves only as a second-line therapy for symptomatic bradycardia after atropine and transcutaneous pacing have failed or are unavailable 1. The 2019 ACC/AHA/HRS bradycardia guidelines explicitly state that while case reports describe salutary use, no clinical trials or observational series support its routine use 1.
Critical contraindication: Avoid in settings with coronary ischemia concern, as isoprenaline increases myocardial oxygen demand through beta-1 effects while decreasing coronary perfusion through beta-2 vasodilation 1, 2.
- Dosing for bradycardia: 2-10 mcg/min IV infusion, titrated to hemodynamic response 1, 3
- Electrophysiology laboratory use: 1-20 mcg/min IV 1
Important negative evidence: Two RCTs showed isoprenaline as adjunctive therapy in cardiac arrest did NOT improve return of spontaneous circulation or survival to hospital discharge 1.
2. Distributive Shock and Reduced Cardiac Output
The FDA label indicates isoprenaline for improving hemodynamic status in distributive shock and shock due to reduced cardiac output 3.
Dosing for shock:
- Start at 0.5-5 mcg/min IV infusion (dilute 1 mg in 500 mL D5W)
- Titrate based on heart rate, central venous pressure, systemic blood pressure, and urine flow
- Rates >30 mcg/min have been used in advanced shock stages
- Decrease or temporarily discontinue if heart rate exceeds 110 bpm 3
3. Bronchospasm During Anesthesia
Dosing: 10-20 mcg IV bolus (dilute 0.2 mg to 10 mL); may repeat as necessary 3
4. Specialized Applications
Tilt table testing: Incremental infusion 1-3 mcg/min to increase heart rate by 20-25% over baseline for vasovagal syncope evaluation 4. Contraindicated in ischemic heart disease, uncontrolled hypertension, LV outflow obstruction, and significant aortic stenosis 4.
Torsades de pointes with acquired long QT: May be considered when accompanied by bradycardia or pause-dependent arrhythmias 5. However, avoid in familial long QT syndrome 5.
Absolute Contraindications (FDA Label)
Per the FDA label, isoprenaline is contraindicated in 3:
- Tachycardia
- Ventricular arrhythmias
- Angina pectoris
Critical Warnings and Precautions
Cardiac Risks
- Induces cardiac arrhythmias and myocardial ischemia, especially in patients with coronary artery disease or cardiomyopathy 3
- Risk of potentially lethal arrhythmias with IV administration 6
Sulfite Allergy
Contains sodium metabisulfite, which may cause mild to severe allergic reactions including anaphylaxis, particularly in sulfite-sensitive patients 3. However, this should not preclude emergency use when alternatives are inadequate 3.
Drug Interactions
Do NOT administer simultaneously with epinephrine—combined direct cardiac stimulation may induce serious arrhythmias 3.
Potentiation of effects (monitor hemodynamics closely):
- Tricyclic antidepressants
- MAO inhibitors
- Levothyroxine
- Certain antihistamines (chlorpheniramine, tripelennamine, diphenhydramine) 3
Antagonism of effects:
- Beta-blockers (propranolol) antagonize cardiostimulating and bronchodilating effects 3
Alternatives by Clinical Scenario
For Bradycardia:
- First-line: Atropine 0.5-2 mg IV 1
- Second-line: Transcutaneous pacing 1
- Alternative vasopressor: Dopamine 5-20 mcg/kg/min (showed no difference vs. pacing in one trial) 1
- Alternative inotrope: Epinephrine 0.1-0.5 mcg/kg/min 7
For Shock:
- Norepinephrine: 0.1-0.5 mcg/kg/min for severe hypotension with low peripheral resistance 7
- Dopamine: 5-10 mcg/kg/min for hypotension with bradycardia 7
- Dobutamine: 5-10 mcg/kg/min for cardiogenic shock 7
For Beta-Blocker/Calcium Channel Blocker Overdose with Bradycardia:
- Glucagon: 1-5 mg IV bolus, then infusion 1
- High-dose insulin therapy 1
- Calcium (for calcium channel blocker overdose) 1
Common Pitfalls
Using isoprenaline in patients with coronary disease: The beta-2 vasodilation decreases coronary perfusion while beta-1 stimulation increases oxygen demand—a dangerous mismatch 1, 2
Administering with epinephrine: This combination can cause lethal arrhythmias 3
Using as first-line for bradycardia: Always try atropine and pacing first 1
Inadequate monitoring: Continuous hemodynamic monitoring is essential during IV administration 6
Ignoring heart rate threshold: Decrease or stop infusion if heart rate exceeds 110 bpm 3